Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT07143071

EndoVascular Aortic Dissection Early vs Delayed

Sponsor: Shanghai Zhongshan Hospital

View on ClinicalTrials.gov

Summary

This is a prospective, multicenter, non-inferior, parallel-controlled observational study. This study aims to compare clinical outcomes of endovascular treatment for acute high-risk type B aortic dissection in the acute phase versus the subacute phase. No interventions will be imposed on the patients' standard treatment. Patients with acute high-risk type B aortic dissection will be grouped based on the actual timing of their treatment.

Official title: Endovascular Treatment for Acute High-risk Type B Aortic Dissection in Acute VS Subacute Phase: a Prospective, Multicenter, Non-inferior, Parallel Controlled Trial

Key Details

Gender

All

Age Range

18 Years - 80 Years

Study Type

OBSERVATIONAL

Enrollment

4068

Start Date

2025-07-01

Completion Date

2030-07-31

Last Updated

2025-08-27

Healthy Volunteers

No

Interventions

PROCEDURE

Acute Phase

Patients with acute high-risk type B aortic dissection received endovascular treatment in acute phase (2-14days)

PROCEDURE

Subacute Phase

Patients with acute high-risk type B aortic dissection received endovascular treatment in subacute phase (≥14days)

Locations (1)

Shanghai Zhongshan Hospital

Shanghai, China